Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Polymerase I and Transcript Release Factor (PTRF) (C-Term) Peptide

PTRF Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5511461
  • Target See all PTRF products
    PTRF (Polymerase I and Transcript Release Factor (PTRF))
    Protein Region
    C-Term
    Origin
    Human
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    EESRAERIKR SGLRRVDDFK KAFSKEKMEK TKVRTRENLE KTRLKTKENL
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-PTRF Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    PTRF (Polymerase I and Transcript Release Factor (PTRF))
    Background
    This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy.

    Alias Symbols: PTRF, FKSG13,

    Protein Size: 390
    Gene ID
    284119
    NCBI Accession
    NP_036364
    UniProt
    Q6NZI2
You are here:
Support